Related Experiment Video
Updated: Apr 8, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Preeclampsia management prioritizes maternal safety. Early detection through prenatal care is crucial. Delivery is the only cure, but expectant management may be considered for severe cases before 34 weeks to improve neonatal outcomes.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Perinatology
Background:
- Preeclampsia, a pregnancy-induced hypertensive disorder, often presents with no clinical symptoms, necessitating regular screening.
- Adequate prenatal care is vital for identifying at-risk pregnancies, early detection, and monitoring disease progression.
Purpose of the Study:
- To review the management strategies for preeclampsia, focusing on maternal safety and fetal outcomes.
- To evaluate the role of expectant management in severe preeclampsia before 34 weeks gestation.
Main Methods:
- Review of clinical guidelines and literature on preeclampsia management.
- Analysis of studies comparing delivery versus expectant management for severe preeclampsia.
Main Results:
- Delivery is the definitive treatment for preeclampsia; however, expectant management in select cases before 34 weeks may improve neonatal outcomes.
- Hypertension is a key symptom, but cerebral involvement poses serious maternal risks.
- Pharmacological control of hypertension is accepted, but its role in prolonging pregnancy is debated.
Conclusions:
- Maternal safety is the primary goal in preeclampsia management.
- Expectant management of severe preeclampsia between 24 and 32 weeks gestation in a specialized setting can be safe and beneficial for neonates.
- Close maternal and fetal monitoring is essential for all preeclampsia patients, especially those undergoing expectant management.
More Related Videos
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
10:44A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function
Published on: June 2, 2019
Related Concept Videos
Hypertension V: Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Mitral Valve Prolapse III: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hormonal Regulation